Biodexa Pharmaceuticals (BDRX) Interest Coverage Ratio (2013 - 2025)

Biodexa Pharmaceuticals (BDRX) has 12 years of Interest Coverage Ratio data on file, last reported at 14.87 in Q2 2025.

• For the quarter ending Q2 2025, Interest Coverage Ratio changed N/A year-over-year to 14.87; the trailing twelve-month figure through Jun 2025 stood at 85.36 (changed N/A YoY), and the FY2025 full-year result was 37.75, up 32.29% from the prior year.
• Interest Coverage Ratio slipped to 14.87 in Q2 2025, from 86.18 in the prior quarter.
• In the past five years, Interest Coverage Ratio ranged from a high of 192.91 in Q2 2023 to a low of 14.87 in Q2 2025.
• A 5-year average of 88.64 and a median of 86.18 in 2024 frame the typical range for Interest Coverage Ratio.
• Across the five-year window, Interest Coverage Ratio tumbled 61.22% in 2021 and surged 659.34% in 2022, its largest moves.
• Tracing BDRX's Interest Coverage Ratio over 5 years: stood at 20.73 in 2021, then jumped by 659.34% to 157.42 in 2022, then advanced by 22.55% to 192.91 in 2023, then tumbled by 55.32% to 86.18 in 2024, then slumped by 117.26% to 14.87 in 2025.
• Business Quant data shows BDRX's Interest Coverage Ratio at 14.87 in Q2 2025, 86.18 in Q4 2024, and 192.91 in Q2 2023.